Literature DB >> 11390603

Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivity.

Y Xiang1, R Thorick, M L Vana, R Craven, J Leis.   

Abstract

The formation of the mature carboxyl terminus of CA in avian sarcoma/leukemia virus is the result of a sequence of cleavage events at three PR sites that lie between CA and NC in the Gag polyprotein. The initial cleavage forms the amino terminus of the NC protein and releases an immature CA, named CA1, with a spacer peptide at its carboxyl terminus. Cleavage of either 9 or 12 amino acids from the carboxyl terminus creates two mature CA species, named CA2 and CA3, that can be detected in avian sarcoma/leukemia virus (R. B. Pepinsky, I. A. Papayannopoulos, E. P. Chow, N. K. Krishna, R. C. Craven, and V. M. Vogt, J. Virol. 69:6430-6438, 1995). To study the importance of each of the three CA proteins, we introduced amino acid substitutions into each CA cleavage junction and studied their effects on CA processing as well as virus assembly and infectivity. Preventing cleavage at any of the three sites produced noninfectious virus. In contrast, a mutant in which cleavage at site 1 was enhanced so that particles contained CA2 and CA3 but little detectable CA1 was infectious. These results support the idea that infectivity of the virus is closely linked to proper processing of the carboxyl terminus to form two mature CA proteins.

Entities:  

Mesh:

Year:  2001        PMID: 11390603      PMCID: PMC114317          DOI: 10.1128/JVI.75.13.6016-6021.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.

Authors:  D K Worthylake; H Wang; S Yoo; W I Sundquist; C P Hill
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

Review 2.  Site-directed mutagenesis using overlap extension PCR.

Authors:  A Aiyar; Y Xiang; J Leis
Journal:  Methods Mol Biol       Date:  1996

3.  A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.

Authors:  M A Accola; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  A conformational switch controlling HIV-1 morphogenesis.

Authors:  I Gross; H Hohenberg; T Wilk; K Wiegers; M Grättinger; B Müller; S Fuller; H G Kräusslich
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

6.  Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

Authors:  R B Pepinsky; I A Papayannopoulos; E P Chow; N K Krishna; R C Craven; V M Vogt
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Genetic determinants of Rous sarcoma virus particle size.

Authors:  N K Krishna; S Campbell; V M Vogt; J W Wills
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Assembly and analysis of conical models for the HIV-1 core.

Authors:  B K Ganser; S Li; V Y Klishko; J T Finch; W I Sundquist
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

9.  Programming the Rous sarcoma virus protease to cleave new substrate sequences.

Authors:  T W Ridky; D Bizub-Bender; C E Cameron; I T Weber; A Wlodawer; T Copeland; A M Skalka; J Leis
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.

Authors:  T W Ridky; A Kikonyogo; J Leis; S Gulnik; T Copeland; J Erickson; A Wlodawer; I Kurinov; R W Harrison; I T Weber
Journal:  Biochemistry       Date:  1998-09-29       Impact factor: 3.162

View more
  5 in total

1.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease.

Authors:  Steven C Pettit; Jose C Clemente; Jennifer A Jeung; Ben M Dunn; Andrew H Kaplan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.

Authors:  Paul W Keller; Marc C Johnson; Volker M Vogt
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

4.  Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

Authors:  Lisa Z Scheifele; Scott P Kenney; Tina M Cairns; Rebecca C Craven; Leslie J Parent
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

5.  Mutations affecting cleavage at the p10-capsid protease cleavage site block Rous sarcoma virus replication.

Authors:  Marcy L Vana; Aiping Chen; Peter Boross; Irene Weber; Dalbinder Colman; Eric Barklis; Jonathan Leis
Journal:  Retrovirology       Date:  2005-09-27       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.